Vault-13

Birchview Capital, LP

BURLINGTON, VT · CIK 1618205 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$213.8m reported value +21.7% vs Q1 2026
72positions
59.9%in top 10
14 new 17 added 22 reduced 15 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 KLA CORP COM NEW KLAC KLAC 178,471 $53.8m25.18% 25.18% ReducedShares held: Q3 2025 218.8k, Q4 2025 218.8k, Q1 2026 198.8k, Q2 2026 178.5k -20.4k -20,359 -10.2%
2 BRISTOL-MYERS SQUIBB CO COM BMY BMY 297,243 $17.1m8.01% 8.01% ReducedShares held: Q3 2025 316.8k, Q4 2025 302.8k, Q1 2026 306.3k, Q2 2026 297.2k -9.0k -9,025 -3.0%
3 LAM RESEARCH CORP COM NEW LRCX LRCX 35,000 $15.2m7.09% 7.09% ReducedShares held: Q3 2025 0, Q4 2025 40.3k, Q1 2026 36.0k, Q2 2026 35.0k -1.0k -1,000 -2.8%
4 INTELLIA THERAPEUTICS INC COM NTLA NTLA 385,900 $6.8m3.17% 3.17% ReducedShares held: Q3 2025 60.0k, Q4 2025 315.4k, Q1 2026 445.4k, Q2 2026 385.9k -59.5k -59,500 -13.4%
5 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 666,196 $6.7m3.11% 3.11% AddedShares held: Q3 2025 297.0k, Q4 2025 706.0k, Q1 2026 626.0k, Q2 2026 666.2k +40.2k +40,216 6.4%
6 BIODESIX INC COM COM 286,804 $6.5m3.02% 3.02% UnchangedShares held: Q3 2025 286.8k, Q4 2025 286.8k, Q1 2026 286.8k, Q2 2026 286.8k
7 STOKE THERAPEUTICS INC COM STOK STOK 178,110 $5.8m2.73% 2.73% ReducedShares held: Q3 2025 210.0k, Q4 2025 260.0k, Q1 2026 210.0k, Q2 2026 178.1k -31.9k -31,890 -15.2%
8 OVINTIV INC COM OVV OVV 107,500 $5.7m2.65% 2.65% UnchangedShares held: Q3 2025 107.5k, Q4 2025 107.5k, Q1 2026 107.5k, Q2 2026 107.5k
9 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 81,000 $5.7m2.64% 2.64% AddedShares held: Q3 2025 4.0k, Q4 2025 31.0k, Q1 2026 31.0k, Q2 2026 81.0k +50.0k +50,000 161.3%
10 CORCEPT THERAPEUTICS INC COM CORT CORT 57,200 $5.0m2.33% 2.33% AddedShares held: Q3 2025 67.2k, Q4 2025 67.2k, Q1 2026 47.2k, Q2 2026 57.2k +10.0k +10,000 21.2%
11 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 27,190 $4.6m2.14% 2.14% UnchangedShares held: Q3 2025 28.7k, Q4 2025 27.2k, Q1 2026 27.2k, Q2 2026 27.2k
12 PROTHENA CORP PLC SHS PRTA PRTA 449,019 $4.4m2.06% 2.06% UnchangedShares held: Q3 2025 549.0k, Q4 2025 441.0k, Q1 2026 449.0k, Q2 2026 449.0k
13 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 171,000 $4.3m2.02% 2.02% UnchangedShares held: Q3 2025 171.0k, Q4 2025 171.0k, Q1 2026 171.0k, Q2 2026 171.0k
14 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 35,018 $4.3m2.01% 2.01% AddedShares held: Q3 2025 48.0k, Q4 2025 55.0k, Q1 2026 35.0k, Q2 2026 35.0k +18 +18 0.1%
15 COMPASS THERAPEUTICS INC COM CMPX CMPX 1,675,000 $3.7m1.72% 1.72% AddedShares held: Q3 2025 872.9k, Q4 2025 1.6m, Q1 2026 1.5m, Q2 2026 1.7m +209.1k +209,133 14.3%
16 RELMADA THERAPEUTICS INC COM RLMD RLMD 408,100 $2.8m1.32% 1.32% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 409.4k, Q2 2026 408.1k -1.3k -1,287 -0.3%
17 ALKERMES PLC SHS ALKS ALKS 50,000 $2.6m1.23% 1.23% UnchangedShares held: Q3 2025 50.0k, Q4 2025 50.0k, Q1 2026 50.0k, Q2 2026 50.0k
18 HALOZYME THERAPEUTICS INC COM HALO HALO 33,251 $2.6m1.22% 1.22% AddedShares held: Q3 2025 10.1k, Q4 2025 10.1k, Q1 2026 10.1k, Q2 2026 33.3k +23.2k +23,151 229.2%
19 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 69,900 $2.6m1.22% 1.22% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 70.1k, Q2 2026 69.9k -195 -195 -0.3%
20 CYTOKINETICS INC COM NEW CYTK CYTK 30,000 $2.6m1.20% 1.20% UnchangedShares held: Q3 2025 30.0k, Q4 2025 30.0k, Q1 2026 30.0k, Q2 2026 30.0k
21 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 199,000 $2.5m1.16% 1.16% ReducedShares held: Q3 2025 174.0k, Q4 2025 269.0k, Q1 2026 219.0k, Q2 2026 199.0k -20.0k -20,000 -9.1%
22 VERA THERAPEUTICS INC CL A VERA VERA 57,758 $2.5m1.16% 1.16% AddedShares held: Q3 2025 0, Q4 2025 44.0k, Q1 2026 44.0k, Q2 2026 57.8k +13.8k +13,758 31.3%
23 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 4,506 $2.4m1.14% 1.14% AddedShares held: Q3 2025 3.0k, Q4 2025 3.0k, Q1 2026 4.5k, Q2 2026 4.5k +6 +6 0.1%
24 ZENAS BIOPHARMA INC COM ZBIO ZBIO 93,601 $2.4m1.11% 1.11% AddedShares held: Q3 2025 16.5k, Q4 2025 0, Q1 2026 70.0k, Q2 2026 93.6k +23.6k +23,601 33.7%
25 UNIQURE NV SHS QURE QURE 50,697 $2.3m1.09% 1.09% ReducedShares held: Q3 2025 78.7k, Q4 2025 30.8k, Q1 2026 100.7k, Q2 2026 50.7k -50.0k -50,000 -49.6%
26 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 1,350,000 $2.3m1.06% 1.06% ReducedShares held: Q3 2025 500.0k, Q4 2025 500.0k, Q1 2026 1.5m, Q2 2026 1.4m -150.0k -150,000 -10.0%
27 ABIVAX SA SPONSORED ADS ABVX ABVX 17,000 $2.3m1.06% 1.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 17.0k
28 VIR BIOTECHNOLOGY INC COM VIR VIR 220,000 $2.2m1.05% 1.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 220.0k
29 BIOGEN INC COM BIIB BIIB 9,000 $1.9m0.91% 0.91% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.0k, Q2 2026 9.0k +4.0k +4,000 80.0%
30 EQT CORP COM EQT EQT 34,619 $1.8m0.86% 0.86% UnchangedShares held: Q3 2025 34.6k, Q4 2025 34.6k, Q1 2026 34.6k, Q2 2026 34.6k
31 BIOAGE LABS INC COM BIOA BIOA 69,000 $1.7m0.79% 0.79% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 69.0k
32 TRAVERE THERAPEUTICS INC COM TVTX TVTX 29,000 $1.6m0.77% 0.77% ReducedShares held: Q3 2025 43.1k, Q4 2025 43.0k, Q1 2026 29.2k, Q2 2026 29.0k -200 -200 -0.7%
33 QUIDEL CORP COM QDEL QDEL 89,377 $1.6m0.73% 0.73% AddedShares held: Q3 2025 72.5k, Q4 2025 72.5k, Q1 2026 82.5k, Q2 2026 89.4k +6.8k +6,829 8.3%
34 AXSOME THERAPEUTICS INC COM AXSM AXSM 6,000 $1.5m0.69% 0.69% UnchangedShares held: Q3 2025 6.0k, Q4 2025 6.1k, Q1 2026 6.0k, Q2 2026 6.0k
35 FOGHORN THERAPEUTICS INC COM FHTX FHTX 281,937 $1.4m0.64% 0.64% AddedShares held: Q3 2025 281.7k, Q4 2025 281.7k, Q1 2026 281.7k, Q2 2026 281.9k +207 +207 0.1%
36 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 313,616 $1.3m0.62% 0.62% ReducedShares held: Q3 2025 154.0k, Q4 2025 462.7k, Q1 2026 463.6k, Q2 2026 313.6k -150.0k -149,983 -32.4%
37 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 24,000 $1.3m0.60% 0.60% ReducedShares held: Q3 2025 78.0k, Q4 2025 90.0k, Q1 2026 100.0k, Q2 2026 24.0k -76.0k -76,000 -76.0%
38 XENON PHARMACEUTICALS INC COM XENE XENE 21,032 $1.3m0.59% 0.59% AddedShares held: Q3 2025 21.0k, Q4 2025 21.0k, Q1 2026 21.0k, Q2 2026 21.0k +32 +32 0.1%
39 NOVO-NORDISK A S ADR NVO NVO 24,000 $1.2m0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 24.0k
40 FREEPORT-MCMORAN INC CL B FCX FCX 18,035 $1.1m0.53% 0.53% ReducedShares held: Q3 2025 18.0k, Q4 2025 18.0k, Q1 2026 18.0k, Q2 2026 18.0k -5 -5 -0.0%
41 IMMUNOME INC COM IMNM IMNM 50,000 $1.1m0.50% 0.50% UnchangedShares held: Q3 2025 105.0k, Q4 2025 130.0k, Q1 2026 50.0k, Q2 2026 50.0k
42 PHARVARIS N V COM PHVS PHVS 29,847 $1.0m0.48% 0.48% UnchangedShares held: Q3 2025 14.8k, Q4 2025 29.8k, Q1 2026 29.8k, Q2 2026 29.8k
43 HARROW INC COM HROW HROW 24,000 $1.0m0.48% 0.48% UnchangedShares held: Q3 2025 40.0k, Q4 2025 34.0k, Q1 2026 24.0k, Q2 2026 24.0k
44 ADAGENE INC ADS ADAG ADAG 240,000 $1.0m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 240.0k
45 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 20,000 $940.8k0.44% 0.44% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.0k
46 SILENCE THERAPEUTICS PLC ADS SLN SLN 71,218 $782.0k0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 71.2k
47 BRIDGEBIO PHARMA INC COM BBIO BBIO 8,741 $651.0k0.30% 0.30% AddedShares held: Q3 2025 8.7k, Q4 2025 8.7k, Q1 2026 8.7k, Q2 2026 8.7k +53 +53 0.6%
48 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 48,505 $645.1k0.30% 0.30% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 48.5k
49 UROGEN PHARMA LTD COM URGN URGN 16,487 $606.7k0.28% 0.28% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 16.5k
50 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 55,000 $596.8k0.28% 0.28% ReducedShares held: Q3 2025 85.0k, Q4 2025 195.0k, Q1 2026 195.0k, Q2 2026 55.0k -140.0k -140,000 -71.8%
51 CAMP4 THERAPEUTICS CORP COM CAMP CAMP 120,000 $524.4k0.25% 0.25% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 120.0k
52 SAVARA INC COM SVRA SVRA 80,000 $492.8k0.23% 0.23% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.0k
53 CANDEL THERAPEUTICS INC COM CADL CADL 47,756 $491.9k0.23% 0.23% ReducedShares held: Q3 2025 60.0k, Q4 2025 60.0k, Q1 2026 60.0k, Q2 2026 47.8k -12.2k -12,244 -20.4%
54 ALTIMMUNE INC COM NEW ALT ALT 152,681 $464.1k0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 152.7k
55 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 30,000 $424.5k0.20% 0.20% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 375.0k, Q2 2026 30.0k -345.0k -345,000 -92.0%
56 KARYOPHARM THERAPEUTICS INC COM COM 42,952 $419.6k0.20% 0.20% ReducedShares held: Q3 2025 28.0k, Q4 2025 0, Q1 2026 84.0k, Q2 2026 43.0k -41.0k -41,000 -48.8%
57 CULLINAN THERAPEUTICS INC COM CGEM CGEM 20,000 $364.2k0.17% 0.17% UnchangedShares held: Q3 2025 20.0k, Q4 2025 20.0k, Q1 2026 20.0k, Q2 2026 20.0k
58 TRINITY CAP INC COM TRIN TRIN 20,000 $357.8k0.17% 0.17% UnchangedShares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 20.0k, Q2 2026 20.0k
59 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 14,352 $345.6k0.16% 0.16% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.4k
60 CASTLE BIOSCIENCES INC COM CSTL CSTL 12,984 $309.7k0.14% 0.14% AddedShares held: Q3 2025 110.6k, Q4 2025 80.6k, Q1 2026 12.9k, Q2 2026 13.0k +84 +84 0.7%
61 INVIVYD INC COM IVVD IVVD 342,275 $298.6k0.14% 0.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 342.3k
62 GRACE THERAPEUTICS INC COM GRCE GRCE 120,000 $272.4k0.13% 0.13% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 50.0k, Q2 2026 120.0k +70.0k +70,000 140.0%
63 KAYNE ANDERSON BDC INC COM SHS KBDC KBDC 20,000 $270.6k0.13% 0.13% UnchangedShares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 20.0k, Q2 2026 20.0k
64 VOYAGER THERAPEUTICS INC COM VYGR VYGR 75,147 $263.0k0.12% 0.12% AddedShares held: Q3 2025 134.9k, Q4 2025 74.9k, Q1 2026 74.9k, Q2 2026 75.1k +229 +229 0.3%
65 PULMONX CORP COM LUNG LUNG 200,543 $260.7k0.12% 0.12% ReducedShares held: Q3 2025 0, Q4 2025 250.6k, Q1 2026 250.2k, Q2 2026 200.5k -49.7k -49,678 -19.9%
66 OCULAR THERAPEUTIX INC COM OCUL OCUL 20,655 $202.8k0.09% 0.09% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 320.0k, Q2 2026 20.7k -299.3k -299,345 -93.5%
67 FIBROGEN INC COM NEW KYNB KYNB 22,566 $170.4k0.08% 0.08% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 22.6k, Q2 2026 22.6k
68 ELUTIA INC CL A COM ELUT ELUT 165,094 $161.7k0.08% 0.08% UnchangedShares held: Q3 2025 711.2k, Q4 2025 263.0k, Q1 2026 165.1k, Q2 2026 165.1k
69 QUOIN PHARMACEUTICALS LTD SPONSORED ADS QNRX QNRX 20,000 $96.8k0.05% 0.05% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.0k, Q2 2026 20.0k
70 LIPOCINE INC NEW COM NEW LPCN LPCN 16,712 $42.8k0.02% 0.02% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 111.8k, Q2 2026 16.7k -95.1k -95,074 -85.0%
71 DOCGO INC COM DCGO DCGO 39,062 $20.2k0.01% 0.01% ReducedShares held: Q3 2025 764.1k, Q4 2025 49.9k, Q1 2026 39.6k, Q2 2026 39.1k -511 -511 -1.3%
72 GOSSAMER BIO INC COM GOSS GOSS 18,176 $3.0k0.00% 0.00% UnchangedShares held: Q3 2025 138.2k, Q4 2025 138.2k, Q1 2026 18.2k, Q2 2026 18.2k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
NOVOCURE LTD NVCR NVCR 202,330 $2.2m202.3k shares
ENGENE HOLDINGS INC 250,000 $1.7m250.0k shares
ULTRAGENYX PHARMACEUTICAL IN RARE RARE 62,000 $1.3m62.0k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 57,000 $1.1m57.0k shares
VERASTEM INC VSTM VSTM 150,000 $795.0k150.0k shares
APOGEE THERAPEUTICS INC 9,000 $757.5k9.0k shares
APELLIS PHARMACEUTICALS INC APLS APLS 14,000 $563.2k14.0k shares
IDEAYA BIOSCIENCES INC IDYA IDYA 16,860 $561.8k16.9k shares
ARCUS BIOSCIENCES INC RCUS RCUS 25,889 $559.2k25.9k shares
REGENXBIO INC RGNX RGNX 66,270 $555.3k66.3k shares
ROCKET PHARMACEUTICALS INC RCKT RCKT 127,025 $454.8k127.0k shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 20,100 $393.2k20.1k shares
OUTSET MED INC OM OM 98,882 $379.7k98.9k shares
PHREESIA INC PHR PHR 14,300 $119.8k14.3k shares
ZENTALIS PHARMACEUTICALS INC ZNTL ZNTL 17,503 $41.0k17.5k shares